And unlike steroid hormones, which stay in the body a long time, peptides have a very short half-life, so they have been shown to be extremely safe
Another two trials from the SURMOUNT programme have recently been published [48, 49]
The Tech: ExoMind Transcranial Magnetic Stimulation (TMS)
10-30ml injectable Vitamin B12 Compound Clean working space, away from children or pets 1cc Insulin Syringe with needle Rubbing alcohol for disinfection We recommend to use 1/2cc of B12 injections every other day, or every third day, or 1.5cc if ingested
Hormone therapy that restores balance, boosts energy, and supports metabolism for improved vitality
Free specialist consultation Benefits Separate from GLP-1 mechanism synergy when combined with Ozempic/Mounjaro 22.7% weight loss in CagriSema (REDEFINE-1, 68 weeks) best result among incretin therapies 10.8% in monotherapy over 26 weeks (Phase 2, Lancet 2021) In T2D on metformin: 15.6% weight, 2.2% HbA1c combined with semaglutide Does NOT cause hypoglycemia (unlike insulin and sulfonylureas) Gradual 16-week titration smooth buildup, minimal side effects Convenient weekly dosing half-life ~7 days Cardiovascular risk reduction in T2D (secondary endpoint REDEFINE-2) Alternative/addition for patients plateauing on GLP-1 monotherapy Who it's for Weight plateau on GLP-1 (Ozempic/Mounjaro) adding cagrilintide gives +610% reduction Patients who don't tolerate high GLP-1 doses lower dose + cagrilintide instead of dose increase T2D on metformin better glycemic and weight control than semaglutide-mono Biohackers / advanced users seeking maximum CagriSema protocol effect Post-surgical weight maintenance (bariatric) adjuvant against recidivism Those wanting SEPARATE appetite control mechanism without duplicating GLP-1 How to take Standard 16-week titration (Novo Nordisk Phase 3 CagriSema): Weeks 14: 0.25 mg subcutaneous once weekly
